<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2FC62E1F-0AE0-4419-877A-F4A734117E6D"><gtr:id>2FC62E1F-0AE0-4419-877A-F4A734117E6D</gtr:id><gtr:name>University of Florence</gtr:name><gtr:address><gtr:line1>via Luigi Sacconi, 6</gtr:line1><gtr:line3>Sesto Fiorentino</gtr:line3><gtr:postCode>1-50019</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEC5FE7D-C329-4D18-9A3A-FAC03968DF93"><gtr:id>FEC5FE7D-C329-4D18-9A3A-FAC03968DF93</gtr:id><gtr:name>San Francisco University</gtr:name><gtr:address><gtr:line1>2130 Fulton Street</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Community Clinical Sciences</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2FC62E1F-0AE0-4419-877A-F4A734117E6D"><gtr:id>2FC62E1F-0AE0-4419-877A-F4A734117E6D</gtr:id><gtr:name>University of Florence</gtr:name><gtr:address><gtr:line1>via Luigi Sacconi, 6</gtr:line1><gtr:line3>Sesto Fiorentino</gtr:line3><gtr:postCode>1-50019</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEC5FE7D-C329-4D18-9A3A-FAC03968DF93"><gtr:id>FEC5FE7D-C329-4D18-9A3A-FAC03968DF93</gtr:id><gtr:name>San Francisco University</gtr:name><gtr:address><gtr:line1>2130 Fulton Street</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/456427B0-D89C-485B-B25A-D49495FAB371"><gtr:id>456427B0-D89C-485B-B25A-D49495FAB371</gtr:id><gtr:firstName>Julie</gtr:firstName><gtr:surname>Parkes</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G106%2F1138"><gtr:id>A9252292-1C37-4E49-B744-9A5C3ADFD763</gtr:id><gtr:title>Tackling the epidemic of chronic liver disease- moving towards earlier detection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G106/1138</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>188419</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Liver and Digestive Health</gtr:department><gtr:description>epidemiology of liver disease &amp;amp; Biomarker research</gtr:description><gtr:id>AEDAB8F4-DC69-478F-815B-03AF3C00A2E0</gtr:id><gtr:impact>Public health and hepatology</gtr:impact><gtr:outcomeId>ojqPFT6Gxta-1</gtr:outcomeId><gtr:partnerContribution>working together to apply for grant funding for rseaerch into biomarkers in liver disease
clinical and research expertise</gtr:partnerContribution><gtr:piContribution>provide content expertise in diagnostic tests and prognostic tests especially in liver disease. Taking forward research conducted in doctorate</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Florence</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Internal Medicine</gtr:department><gtr:description>external validation of biomarker panel</gtr:description><gtr:id>7921B3B0-4CC3-4BDD-A850-C53CB07B8B52</gtr:id><gtr:impact>publication JVH 2010</gtr:impact><gtr:outcomeId>em39mojVB42-2</gtr:outcomeId><gtr:partnerContribution>Provision of serum samples
Comment son drafts of paperwprking together to conduct an external validation of ELf panel in paediatric populaion in Italy</gtr:partnerContribution><gtr:piContribution>analysis of data 
writing draft of paper
commenting on subsequent drafts</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>Georgia</gtr:country><gtr:department>Division of Viral Hepatitis</gtr:department><gtr:description>external validation of biomarker panel</gtr:description><gtr:id>4AE90F34-4ECD-458D-9324-59C1116A41CE</gtr:id><gtr:impact>publication JVH 2010</gtr:impact><gtr:outcomeId>em39mojVB42-1</gtr:outcomeId><gtr:partnerContribution>Provision of serum samples
Comment son drafts of paperwprking together to conduct an external validation of ELf panel in paediatric populaion in Italy</gtr:partnerContribution><gtr:piContribution>analysis of data 
writing draft of paper
commenting on subsequent drafts</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Florence</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>external validation of biomarker panel</gtr:description><gtr:id>43363224-25EF-4E05-89BF-7359B288C1AF</gtr:id><gtr:impact>Nobili V , Parkes J, Bottazzo G, et al Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology. 2009;136:160-7.</gtr:impact><gtr:outcomeId>PYnZXmUKHLg-1</gtr:outcomeId><gtr:partnerContribution>working togther to conduct an external validaiton study in paediatric population.
Porvided serum samples, data. Help to write a scientific paper published in peer reviewed juornal</gtr:partnerContribution><gtr:piContribution>Using serum samples of biomarker panel were 
Analysis of data
Interpretation fo data
Writing of paper for publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of San Francisco (USF)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>biomarker validaiton n HCV-HIV cohort</gtr:description><gtr:id>653642D6-265B-4CBF-89B8-9DBDFA5D6706</gtr:id><gtr:impact>conference abstract</gtr:impact><gtr:outcomeId>B6wP4sV5H9y-1</gtr:outcomeId><gtr:partnerContribution>Working togther on a cohort of people with HCV HIV co -infection to determine the performance of a panel of Biomarkers in predictiing liver fibrosis and clinical utcomes</gtr:partnerContribution><gtr:piContribution>clinical epidemiology and diagnostic test expertise.
Analysis of data
Collaboration on wrtiing papers</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation to Wessex Medical Research Charity</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A2672832-745B-4230-9509-30808EDEDE88</gtr:id><gtr:impact>60 people attended an annual meeting of a local charity that raises money for medical research. I gave a presentation of the work completed on biomarkers in liver disease conducted during my MRC Fellowship, followed by questions and dscussion afterwards.

This seemed to be well recieved and raised the profile of liver disease research both locally and nationally</gtr:impact><gtr:outcomeId>KVwTbMW4oiS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>newspaper article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>10024EF8-21E9-43EA-BB06-01DD7F78FA73</gtr:id><gtr:impact>article on biomarker in liver disease for local press

wider knowledge in lay and professional audeinces of biomarker panel in prediciting liver fibrosis ,&amp;amp; clinical outcomes</gtr:impact><gtr:outcomeId>PKX1VJoaPuz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Lecturership</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>University of Southampton</gtr:fundingOrg><gtr:id>F12A05A1-F069-4FB6-A091-FDE11C8E38A8</gtr:id><gtr:outcomeId>26274CA30AE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Liver Strategy</gtr:description><gtr:geographicReach>Local/Municipal/Regional - UK Only</gtr:geographicReach><gtr:id>0DAEA16A-6466-44C0-9E3F-CE7F9D724FF4</gtr:id><gtr:impact>Membership of advisory Group on prevention of Chronic liver disease which informed the development of the NAtional Liver Disease Startegy for England &amp;amp; Wales</gtr:impact><gtr:outcomeId>GSXixJCeLHw</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>MRC funding for Doctorate provided (1) evidence of External validation of ELF panel biomarkers in predicting liver fibrosis on biopsy, and (2) prediction of clinical outcomes in people with chronic liver disease. This added substantive evidence of performance of this biomarker panel and contributed to the commercialisation and CE marking of the panel.</gtr:description><gtr:id>A3CF1625-D491-466D-81EE-C40E4EF61DC6</gtr:id><gtr:impact>The ELF panel is presently available for use in patients with Chronic liver disease in the NHS. 
Provide evidence to Support the application by Siemens for FDA approval in USA</gtr:impact><gtr:outcomeId>jDx6mG4j7ed</gtr:outcomeId><gtr:stage>Small-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Enhanced Liver Fibrosis (ELF) Panel</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>44590429-2725-45ED-9D51-6DCE6CC01DDA</gtr:id><gtr:title>Performance of serum marker panels for liver fibrosis in chronic hepatitis C.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5c5f87bda0e33e2d19ddab157d2c30f"><gtr:id>a5c5f87bda0e33e2d19ddab157d2c30f</gtr:id><gtr:otherNames>Parkes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>67A5D8F5BD7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEC8B20C-7511-42D6-A257-0B5A9B8CA104</gtr:id><gtr:title>Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.</gtr:title><gtr:parentPublicationTitle>Journal of viral hepatitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5c5f87bda0e33e2d19ddab157d2c30f"><gtr:id>a5c5f87bda0e33e2d19ddab157d2c30f</gtr:id><gtr:otherNames>Parkes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1352-0504</gtr:issn><gtr:outcomeId>D1E3B67039A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2493FDFD-FFC8-4437-BE5D-E194588006F4</gtr:id><gtr:title>Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c39012d8f470d8a64b7932e0b8b64dd"><gtr:id>2c39012d8f470d8a64b7932e0b8b64dd</gtr:id><gtr:otherNames>Nobili V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>4E8FD6A792D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2315FF3-C3C6-497A-9475-8CD2796515D8</gtr:id><gtr:title>Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5c5f87bda0e33e2d19ddab157d2c30f"><gtr:id>a5c5f87bda0e33e2d19ddab157d2c30f</gtr:id><gtr:otherNames>Parkes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>ZBFE7eV3z2W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D16C32FA-1D6E-41B3-95A2-47212D113BE3</gtr:id><gtr:title>Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90ccd88506f176cc05d5121b85a052c4"><gtr:id>90ccd88506f176cc05d5121b85a052c4</gtr:id><gtr:otherNames>Guha IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>760A754816A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17AE30C9-63B3-4D4C-BB46-FF438DB414D1</gtr:id><gtr:title>Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47deee15a7328b78995f9d2fb675c5e8"><gtr:id>47deee15a7328b78995f9d2fb675c5e8</gtr:id><gtr:otherNames>Mayo MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>6F600AC5BD9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC439856-23BF-487D-85A4-FD19B6B075CC</gtr:id><gtr:title>Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90ccd88506f176cc05d5121b85a052c4"><gtr:id>90ccd88506f176cc05d5121b85a052c4</gtr:id><gtr:otherNames>Guha IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>A2B2C78AC92</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G106/1138</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>E4AF608A-CDB6-4CE6-AA10-95B3E043E22F</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>8.1  Organisation and delivery of services</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>